Lian Shuai, Li Xiaoqiong, Lv Xuefei
School of Medical Technology, Beijing Institute of Technology, Beijing 100000, China.
ACS Appl Mater Interfaces. 2025 Feb 19;17(7):10193-10230. doi: 10.1021/acsami.4c17779. Epub 2025 Feb 5.
This paper reviews the latest research progress of surface-enhanced Raman spectroscopy (SERS) microfluidic chips in the field of biosensing. Due to its single-molecule sensitivity, selectivity, minimal or no preprocessing, and immediacy, SERS is considered a promising biosensing technology. However, the nondirectional interactions between biological samples and the substrate, as well as fluctuations in the sample environment temperature during signal acquisition, can affect the stability and reproducibility of SERS signals. Integrating SERS spectroscopy with microfluidic chips not only leverages the continuous sample flow, high reaction efficiency, high throughput, and multifunctionality of microfluidic chips to address challenges in biosensing applications but also expands the scope of microfluidic technology by providing a novel on-chip optical detection method. The combination of SERS and microfluidic chips not only enables the complementary advantages of both technologies but also offers a highly promising "combined technology" for the field of biosensing. This paper starts by introducing the enhancement mechanisms of SERS and presents both labeled and label-free SERS strategies. Based on the differences in substrate properties, we broadly categorize SERS microfluidic chips into colloidal nanoparticle-based SERS microfluidic chips and fixed substrate-based SERS microfluidic chips. Finally, we review the latest research progress on SERS microfluidic chips for biosensing biological targets such as nucleic acids, proteins, small biomolecules, and live cells. In the conclusion and outlook section, we summarize the challenges faced by SERS microfluidic chips in biosensing and propose feasible solutions. To better leverage the role of SERS microfluidic chips in biosensing, we also present an outlook on the future development of this combined technology.
本文综述了表面增强拉曼光谱(SERS)微流控芯片在生物传感领域的最新研究进展。由于其单分子灵敏度、选择性、极少或无需预处理以及即时性,SERS被认为是一种很有前景的生物传感技术。然而,生物样品与基底之间的非定向相互作用以及信号采集过程中样品环境温度的波动,会影响SERS信号的稳定性和可重复性。将SERS光谱与微流控芯片集成,不仅利用了微流控芯片连续的样品流动、高反应效率、高通量和多功能性来应对生物传感应用中的挑战,还通过提供一种新颖的芯片上光学检测方法扩展了微流控技术的范围。SERS与微流控芯片的结合不仅实现了两种技术的互补优势,也为生物传感领域提供了一种极具前景的“组合技术”。本文首先介绍了SERS的增强机制,并介绍了标记和无标记的SERS策略。基于基底性质的差异,我们将SERS微流控芯片大致分为基于胶体纳米颗粒的SERS微流控芯片和基于固定基底的SERS微流控芯片。最后,我们综述了用于检测核酸、蛋白质、小生物分子和活细胞等生物靶标的SERS微流控芯片的最新研究进展。在结论与展望部分,我们总结了SERS微流控芯片在生物传感中面临的挑战并提出了可行的解决方案。为了更好地发挥SERS微流控芯片在生物传感中的作用,我们还展望了这种组合技术的未来发展。